Showing 1 - 20 results of 65 for search 'major of guangzhou', query time: 0.06s Refine Results
  1. 1

    Trends and factors influencing over-the-counter cold and cough medication sales in Guangzhou, China: 2011–2017 by Jian Chen, Daoze Wang, Jialu Zheng, Bing Zhang, Yilin Chen, Haoyu Long, Jinfeng Zeng, Zicheng Cao, Wenjie Han, Gang Wang, Xue Zhang, Jianyun Lu, Zhoubin Zhang, Xiangjun Du

    Published 2025-07-01
    “…Methods We monitored OTCCM sales at 36 stores of a major pharmaceutical chain in Guangzhou, China, from 2011 to 2017. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4

    Beyond quantity: Image segmentation-based assessment on quality of urban green spaces in China’s 20 major cities by Jiayun Ye, Zhuo Chen, Jianquan Dong

    Published 2025-09-01
    “…Southern cities, such as Guangzhou, achieved the highest availability score despite having a low quantity, whereas northeastern cities, like Harbin, had a high quantity but limited diversity and facility scores. …”
    Get full text
    Article
  5. 5
  6. 6
  7. 7
  8. 8

    Case Report: Locally advanced lung adenocarcinoma with a novel MIR217HG-ALK rearrangement responding to neoadjuvant alectinib by Yinyin Xue, Yinyin Xue, Wen Li, Wen Li, Kaili Huang, Kaili Huang, Qinghua Zhou, Qinghua Zhou, Qiang Wu, Qiang Wu

    Published 2025-08-01
    “…Herein, we present a patient with lung adenocarcinoma harboring a novel ALK rearrangement who exhibited major pathological response (MPR) following neoadjuvant treatment with alectinib.Materials and methodsWe conduct immunohistochemistry (IHC) staining with Ventana with D5F3 clone, fluorescence in situ hybridization (FISH, The Vysis ALK Break Apart FISH Probe Kit), and next-generation sequencing (NGS) analyses (Burning Rock, Guangzhou, China) on biopsy sample obtained from the patient.ResultsThe patient, a 66-year-old female, was diagnosed with stage IIIB-N3 adenocarcinoma in the right upper lobe of the lung. …”
    Get full text
    Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Efficacy and safety of neoadjuvant toripalimab plus chemotherapy in localized deficient mismatch repair/microsatellite instability-high gastric or esophagogastric junction adenocar... by Liying Zhao, Hao Liu, Jiang Yu, Shuqiang Yuan, Huayuan Liang, Wei Wang, Junliang Jiang, Lina Yu, Li Liang, Zhao Chen, Xinhua Chen, Xuefeng Zhong, Yating Zheng, Fengping Li, Tian Lin, Mingli Zhao, Tao Chen, Hao Chen, Yanfeng Hu, Guoxin Li

    Published 2025-09-01
    “…Funding: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Beijing Hospitals Authority Clinical Medicine Development, Beijing Natural Science Foundation, Key Clinical Technique of Guangzhou, Key Areas Research and Development Programs of Guangdong Province, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Clinical Research Program of Nanfang Hospital.…”
    Get full text
    Article
  19. 19
  20. 20